It has been recently reported that genes with anti-infective effect (for example CCL5, CD28, IFN gamma) are upregulated and others with pro-infective effect (for example ARC-1, FUT4) are downregulated by TKIs in patients with CML [7]. This evidence concerns the gene CCL5 and chronic myelogenous leukemia, BCR-ABL1 positive.